[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100454591":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":22,"responsibleParty":43,"collaborators":7,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":7,"eligibilityCriteria":51,"healthyVolunteers":48,"sex":52,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":58,"studyType":59,"phases":7,"briefSummary":60,"conditions":61,"keywords":7,"overallStatus":24,"whyStopped":7,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Ann & Robert H Lurie Children's Hospital of Chicago","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Joshua B Wechsler, MD","PRINCIPAL_INVESTIGATOR",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Angela Anthony","CONTACT","312-227-4559","aanthony@luriechildrens.org",{"name":19,"role":15,"phone":20,"phoneExt":7,"email":21},"Mary Riordan","312-227-4558","mriordan@luriechildrens.org",[23],{"facility":5,"status":24,"city":25,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"RECRUITING","Chicago","Illinois","60611","United States","US",{"type":31,"coordinates":32},"Point",[33,34],-87.65005,41.85003,{"lat":34,"lon":33},[37,41,42],{"name":38,"role":15,"phone":39,"phoneExt":7,"email":40},"Zeinab Dehghani, MD","312-227-4656","zdehghani@luriechildrens.org",{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},{"name":10,"role":11,"phone":7,"phoneExt":7,"email":7},{"type":11,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Joshua Wechsler","Principal Investigator","100454591","eosinophilic-gastrointestinal-disorders-registry-100454591",false,"NCT05199532","Eosinophilic Gastrointestinal Disorders Registry","Inclusion Criteria:\n\n* Patients with an established diagnosis of an EGID, based on pathology findings from an endoscopy or colonoscopy with biopsies.\n* Patients suspected of having an EGID and undergoing endoscopic evaluation for further assessment\n\nExclusion Criteria:\n\n* Patients who do not consent to participate","ALL","1 Year","25 Years",{"count":56,"type":57},500,"ESTIMATED","5 Years","OBSERVATIONAL","The purpose of this study is to learn more about Eosinophilic Gastrointestinal Disorders (EGIDs). With this registry we hope to find out more about the symptoms that patients have during their treatment, the quality of life they have with the diagnosis, what the disease looks like throughout the different treatment methods, and if there is a connection between EGIDs and connective tissue disorders.\n\nThe goal of this study is to be able to better understand EGIDs and use information gained from all the information collected on this study for more precise treatments in the future. We want to create a large collection of samples, called a biorepository, to learn the most about EGIDs as possible. When the samples are collected, which will occur at procedures directed by your child's doctor as part of their standard of care, they will be stored for an unlimited amount of time to perform experiments on these samples and to gather information about EGIDs",[62,63,64,65],"Eosinophilic Esophagitis","Eosinophilic Gastroenteritis","Eosinophilic Colitis","Eosinophilic Gastrointestinal Disease","2026-03-16",{"date":68,"type":69},"2026-03-18","ACTUAL",{"date":71,"type":69},"2020-12-18",{"date":73,"type":57},"2035-12",{"name":5,"class":6},1]